SCM
PMD

Segantii Capital Management’s Psychemedics Corporation PMD Stock Holding History

Segantii Capital Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,650
Closed -$113K – 276
2017
Q1 		$113K Buy
+5,650
New +$124K 0.02% 197

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Segantii Capital Management's PMD Position: Q2 2017 in Review

Segantii Capital Management sold out of Psychemedics Corporation (PMD) in Q2 2017, closing a stake of 5,650 shares — an estimated $113K sold.

Segantii Capital Management first reported a position in PMD in Q1 2017 and held it in 1 quarter. The position peaked at $113K in Q1 2017. 58 funds tracked by Wall St. Rank hold PMD as of Q2 2017.

  • Segantii Capital Management reported no remaining Psychemedics Corporation position as of Q2 2017 after selling out during the quarter.
  • Segantii Capital Management sold 5,650 Psychemedics Corporation shares in Q2 2017, an estimated $113K.
  • Segantii Capital Management first reported a position in Psychemedics Corporation in Q1 2017 and held it in 1 quarter.
  • Segantii Capital Management's Psychemedics Corporation position peaked at $113K in Q1 2017.
  • 58 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2017.

Based on Segantii Capital Management's 13F filing for Q2 2017, filed 2 Aug 2017.